RECURRENT PRIMARY PERITONEAL CARCINOSARCOMA
Clinical trials for RECURRENT PRIMARY PERITONEAL CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PRIMARY PERITONEAL CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT PRIMARY PERITONEAL CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo shows promise in ovarian cancer fight
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own white blood cells, combined with an immunotherapy drug (pembrolizumab), for people with ovarian cancer that has returned. The vaccine targets a protein found on many ovarian cancer cells, training the immune system…
Matched conditions: RECURRENT PRIMARY PERITONEAL CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
Supercharged immune cells take on Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis early-stage study tests a new treatment for ovarian cancer that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells (T cells) that are trained in a lab to recognize and attack a protein called MUC1 found on cancer cells. The ma…
Matched conditions: RECURRENT PRIMARY PERITONEAL CARCINOSARCOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:57 UTC